[ad_1]
Ashlee Evans-Smith has examined optimistic for a steroid and shall be out of motion till subsequent 12 months.
The USADA announced Monday that Evans-Smith has accepted a sanction for violating the UFC Anti-Doping Coverage after she examined optimistic for “an anabolic androgenic steroid of exogenous origin” tied to a pair of out-of-competition drug checks taken this previous January. The outcomes got here from urine samples collected on Jan. 3 and Jan. 27.
Evans-Smith will serve a 14-month suspension, which is retroactive to Jan. 3, which implies that she shall be eligible to compete once more on March 3, 2023. The 34-year-old has not fought since shedding a unanimous choice to Norma Dumont in a 139.5-pound catchweight bout (Dumont missed weight by 3.5 kilos) at UFC Vegas 15 in November 2020.
Based on the USADA’s assertion, Evans-Smith had declared dehydroepiandrosterone (DHEA) on her doping management types and later offered proof that the substance had been incorrectly prescribed to her. As a consequence of Evans-Smith’s cooperation with the investigation, it was decided that the fighter’s “diploma of fault was diminished and that she ought to obtain a diminished interval of ineligibility.”
That is the second time in Evans-Smith’s UFC profession that she has been suspended for a failed drug take a look at. In February 2015, she was issued a nine-month suspension by the Nevada Athletic Fee after testing optimistic for a diuretic, hydrochlorizide, in relation to a bout at UFC 181. Evans-Smith was additionally fined 30 p.c of her present cash for that bout, which got here out to $2,400.
Evans-Smith (6-5) has misplaced 4 of her previous 5 fights and her UFC file sits at 3-5.
[ad_2]
Source link
